Stock Market News

2 days Here’s Why Arcutis Stock More Than Doubled in Market Value in One Year Zacks

The rally in ARQT’s stock could be attributed to the encouraging regulatory updates seeking label expansion for its sole marketed drug.

2 days A successful VC predicts what the next 10 years in the venture capital industry will look like Business Insider

2 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks

3 days Looks Like Tech will lead this year again. Reddit

3 days Neumora Therapeutics’ stock craters after trial of major depressive disorder fails to meet main goals MarketWatch

3 days MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN Zacks

3 days 5 Large Drug Stocks to Keep An Eye On in the New Year Zacks

3 days Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? Zacks

4 days All You Need to Know About Puma Biotech (PBYI) Rating Upgrade to Strong Buy Zacks

5 days Amgen (AMGN) Advances While Market Declines: Some Information for Investors Zacks

6 days This Biotech Is One of the S&P 500’s Worst Performers. It Looks Too Cheap. Yahoo Finance

6 days Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights Zacks

6 days Friday’s Insider Activity: Top Execs Make Moves in Biotech and Retail Investing.com

1 week Buffett Is Still Buying, Plus Insiders Love These 2 Biotech Stocks 24/7 Wall St.

1 week Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy Seeking Alpha

1 week How Tarsus Pharmaceuticals’ Unique Inspiration Is Driving A Triple-Digit Run Investor's Business Daily

1 week 2025 Analyst Outlook: Edmund Ingham On Biotech Big And Small, And A Key Milestone Seeking Alpha

2 weeks 4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow Zacks

2 weeks Should You Invest in the VanEck Biotech ETF (BBH)? Zacks

2 weeks Here’s Why Amgen (AMGN) Gained But Lagged the Market Today Zacks

2 weeks 5 Biotech Breakthrough Stocks to Watch in 2025 Zacks

2 weeks Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks

2 weeks Investors optimistic about continued biotech and medtech IPO resurgence in 2025 Yahoo Finance

2 weeks This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy? Yahoo Finance

2 weeks Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? Zacks

2 weeks 4 Biotech Stocks Most Wall Street Analysts Are Bullish About Zacks

2 weeks KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707 Zacks

2 weeks Merck Enters Obesity Space, Buys Rights to Hansoh’s Oral GLP-1 Drug Zacks

3 weeks Top-Notch Biotech Mesoblast Skyrockets On Immune Condition Approval Investor's Business Daily

3 weeks Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks

3 weeks 3 No-Brainer Biotech Stocks to Buy With $200 Right Now Yahoo Finance

3 weeks Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks

3 weeks How to play a potential biotech breakout in 2025 with options CNBC

3 weeks 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

3 weeks 3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025 Zacks

3 weeks ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

3 weeks ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

3 weeks Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 Yahoo Finance

3 weeks KRYS Stock Down on Initial Clinical Updates on KB407 & KB408 Zacks

3 weeks RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead MarketWatch

3 weeks The Ultimate Biotech Stock to Buy With $500 Right Now Yahoo Finance

4 weeks Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks

4 weeks Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More Zacks

4 weeks Investors Slaughter Q32 Bio On A ‘Messy’ Update In Eczema, Alopecia Treatment Investor's Business Daily

4 weeks Candel Skyrockets 68% On A Potential First-In-20-Years Cancer Drug Investor's Business Daily

4 weeks Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell? Zacks

4 weeks NewAmsterdam Pharma Soars 41% On A Surprise Benefit From Cholesterol Drug Investor's Business Daily

4 weeks CervoMed’s stock craters 77% after failed trial of treatment for rare brain disease MarketWatch

4 weeks Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Zacks

4 weeks Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? Zacks

4 weeks Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. Investor's Business Daily